Treatment of tuberculosis using a combination of sustained-release rifampin-loaded microspheres and oral dosing with isoniazid
about
Preparation and evaluation of gelatin/sodium carboxymethyl cellulose polyelectrolyte complex microparticles for controlled delivery of isoniazid.Animal welfare in studies on murine tuberculosis: assessing progress over a 12-year period and the need for further improvement.A novel approach for lung delivery of rifampicin-loaded liposomes in dry powder form for the treatment of tuberculosis.Fighting tuberculosis: old drugs, new formulations.Efficacy of rifabutin-loaded microspheres for treatment of Mycobacterium avium-infected macrophages and mice.Toward an optimized treatment of intracellular bacterial infections: input of nanoparticulate drug delivery systems.Formulation and in vitro evaluation of rifampicin loaded porous microspheres.Chemotherapeutic potential of orally administered poly(lactide-co-glycolide) microparticles containing isoniazid, rifampin, and pyrazinamide against experimental tuberculosis.Sustained release characteristics of rifampin-loaded microsphere formulations in nonhuman primates.In vitro susceptibility of Mycobacterium tuberculosis to extracts of Eucalyptus camaldulensis and Eucalyptus torelliana and isolated compounds.Biodegradable micro- and nanoparticles as long-term delivery vehicles for gentamicin.Long-acting formulations for the treatment of latent tuberculous infection: opportunities and challenges.Converging layer-by-layer polyelectrolyte microcapsule and cubic lyotropic liquid crystalline nanoparticle approaches for molecular encapsulation
P2860
Q30915887-5C7E30CD-86E6-436D-89D2-8947D1F262B5Q34460532-588FD70C-CD6B-4F7C-ADEF-B16B92BC048BQ35851344-CA3D327C-BB9A-480C-97C8-43C5D26048E6Q37579212-98C1E838-62AA-4BF4-99CD-0A5DF3E5EFD5Q40142069-676DFD44-7954-46CD-9D41-CAD247523AD8Q40974806-0CCEB4EC-C817-4CFA-AA44-24EEBE5BE32BQ41182319-A5C8BBCC-F57C-4A6D-81D5-7085577730E3Q42925122-D27E16E3-9B1A-45A8-86AB-DFA2CBC5AB5CQ45061531-45A912BC-B0A1-43D3-A869-967828DAA280Q47246017-AA5EBF01-530F-4B0A-8152-52D07F546DB6Q51101044-FF4A412A-D64E-469D-83AC-6EE3A6952DD3Q52673482-20E9CBD1-C9DE-411D-A94E-2132A5058164Q57645149-C871C25C-3617-45D1-AC90-46743CDF71EA
P2860
Treatment of tuberculosis using a combination of sustained-release rifampin-loaded microspheres and oral dosing with isoniazid
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Treatment of tuberculosis usin ...... and oral dosing with isoniazid
@ast
Treatment of tuberculosis usin ...... and oral dosing with isoniazid
@en
Treatment of tuberculosis usin ...... and oral dosing with isoniazid
@nl
type
label
Treatment of tuberculosis usin ...... and oral dosing with isoniazid
@ast
Treatment of tuberculosis usin ...... and oral dosing with isoniazid
@en
Treatment of tuberculosis usin ...... and oral dosing with isoniazid
@nl
prefLabel
Treatment of tuberculosis usin ...... and oral dosing with isoniazid
@ast
Treatment of tuberculosis usin ...... and oral dosing with isoniazid
@en
Treatment of tuberculosis usin ...... and oral dosing with isoniazid
@nl
P2093
P2860
P921
P1476
Treatment of tuberculosis usin ...... and oral dosing with isoniazid
@en
P2093
D C Quenelle
E L Barrow
G A Winchester
W W Barrow
P2860
P304
P356
10.1128/AAC.45.6.1637-1644.2001
P407
P577
2001-06-01T00:00:00Z